US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quasi-New Stocks

833.53

+31.813.97%

Number of Gainers:152

Number of Losers:22

Number of Flat:9

PE:- -

High:842.59

Open:801.72

Low:795.09

Close:801.72

Volume:565.59M

Turnover:16.45B

Market Cap:599.29B

Float Cap:439.09B

Loading ...

Alkami Gets a Vote Of Confidence From A Key Investor -- Barron's

Defence Therapeutics Launches $1.2 Million Debenture Units Financing

CFO & Treasurer Howard Fu Reports Disposal of Common Shares of Procore Technologies Inc

Benjamin C. Singer, Chief Legal Officer, Reports Disposal of Procore Technologies Inc. Common Shares

Victoria Valenzuela, CALO & Corp. Secretary, Reports Disposal of Applovin Corp Common Shares

Applovin Corporation CTO Vasily Shikin Reports Disposal of Common Shares

Arash Adam Foroughi, CEO and Chairperson, Reports Disposal of Common Shares in Applovin Corporation

BriaCell Therapeutics trading halted, news pending

thredUP (TDUP) Gets a Buy from William Blair

Decoy Therapeutics Reports Financial Downturn Amid Funding Challenges

Why Recursion Pharmaceuticals Stock Caught a Cold This Week

Chief Medical Officer Hyong Kim Reports Disposal of Common Shares of Alignment Healthcare Inc

Sarah Personette Joins Lifestance Health Board

UTime Limited Completes $25 Million Share Offering and Announces Board Changes

Serina Therapeutics Amends Bylaws for Governance Transparency

Rain Enhancement Technologies Holdco Inc. Appeals Nasdaq Delisting Notice; Awaits Hearing to Regain Compliance

Rain Enhancement Technologies Holdco, Inc. Receives and Appeals Nasdaq Delisting Notice

THOMSON REUTERS

Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025

TScan Therapeutics Inc. Files Initial Beneficial Ownership Statement for Principal Accounting Officer Dworak Leiden

Lyell Immunopharma's Chief Scientific Officer Gary K. Lee Reports Disposal of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4539/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":833.5283,"timestamp":1755892799999,"preClose":801.7168,"halted":0,"volume":565594457,"delay":0,"changeRate":0.039679,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":31.811523,"latestTime":"08-22 16:00:00 EDT","open":801.72455,"high":842.5943,"low":795.08655,"amount":16446125789.66847,"amplitude":0.059258,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756108800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":7.059643,"peRate":260.581301,"turnoverRate":0.042454,"increases":151,"decrements":23,"flats":5,"marketCap":599287481080,"floatMarketCap":439089233575.375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":842.5943,"amplitude":0.059258,"preClose":801.7168,"low":795.08655,"pbRate":"7.059643","latestPrice":833.5283,"volume":565594457,"delay":0,"open":801.72455,"prevYearClose":648.26935,"prevWeekClose":826.7156,"prevMonthClose":818.544,"prevQuarterClose":785.8086,"fiveDayClose":826.7156,"twentyDayClose":834.9997,"sixtyDayClose":717.2554,"secType":"PLATE","market":"US","turnoverRate":0.042454,"peRate":260.581301,"marketCap":599287481080,"floatMarketCap":439089233575.375,"timestamp":1755892799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":152,"down":22,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2561284909","title":"Alkami Gets a Vote Of Confidence From A Key Investor -- Barron's","url":"https://stock-news.laohu8.com/highlight/detail?id=2561284909","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561284909?lang=en_us&edition=fundamental","pubTime":"2025-08-23 09:31","pubTimestamp":1755912660,"startTime":"0","endTime":"0","summary":"Investors have been fleeing Alkami Technology recently. But the cloud-based digital banking platform recently got a big vote of confidence from one of its largest shareholders.Shares of Alkami plunged nearly 22%, from $26.16 on July 30 to $20.49 on Aug. 1, after the company reported disappointing second-quarter earnings. While sales climbed 36% to $112 million, the company missed Wall Street's profit forecasts and issued a tepid revenue outlook.Alkami reported second-quarter operating earnings of two cents a share, far below the eight cents that analysts expected, according to FactSet figures. And its third-quarter sales projection of $112.5 million to $114 million was below the $116.4 million average analyst forecast.On Tuesday, Alkami shares traded at $22.30, down 17 cents, or about 0.8%, from the prior day. They are about 47% below their 52-week closing high of $42.22 hit in November.At least one big investor is doubling down. From Aug. 11 to Aug. 13, investment firm General Atlanti","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ALKT","BK4023"],"gpt_icon":0},{"id":"2561284345","title":"Defence Therapeutics Launches $1.2 Million Debenture Units Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2561284345","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561284345?lang=en_us&edition=fundamental","pubTime":"2025-08-23 09:02","pubTimestamp":1755910949,"startTime":"0","endTime":"0","summary":"Defence Therapeutics ( ($TSE:DTC) ) has shared an update. Defence Therapeutics Inc. has announced a non-brokered private placement of debenture uni...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/defence-therapeutics-launches-1-2-million-debenture-units-financing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/defence-therapeutics-launches-1-2-million-debenture-units-financing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4007","BK4539","BK4139"],"gpt_icon":0},{"id":"2561281509","title":"CFO & Treasurer Howard Fu Reports Disposal of Common Shares of Procore Technologies Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2561281509","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561281509?lang=en_us&edition=fundamental","pubTime":"2025-08-23 08:34","pubTimestamp":1755909259,"startTime":"0","endTime":"0","summary":"Howard Fu, CFO & Treasurer of Procore Technologies Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Procore Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250823:nNDLbgKfn9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4539","PCOR","BK4535"],"gpt_icon":0},{"id":"2561815252","title":"Benjamin C. Singer, Chief Legal Officer, Reports Disposal of Procore Technologies Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2561815252","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561815252?lang=en_us&edition=fundamental","pubTime":"2025-08-23 08:33","pubTimestamp":1755909221,"startTime":"0","endTime":"0","summary":"Benjamin C. Singer, Chief Legal Officer and Secretary of Procore Technologies Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Procore Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 22, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250823:nNDLc2tgWV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4535","PCOR","BK4023"],"gpt_icon":0},{"id":"2561289106","title":"Victoria Valenzuela, CALO & Corp. Secretary, Reports Disposal of Applovin Corp Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2561289106","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561289106?lang=en_us&edition=fundamental","pubTime":"2025-08-23 08:13","pubTimestamp":1755908004,"startTime":"0","endTime":"0","summary":"Victoria Valenzuela, an officer holding the position of CALO & Corp. Secretary at Applovin Corporation, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Applovin Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250823:nNDL5fZpZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APP","IE00B19Z9P08.USD","IE00BZ9MQY76.HKD","BK4585","BK4588","IE00B894F039.SGD","IE00B19Z9Z06.USD","BK4613","BK4539","BK4023","BK4608"],"gpt_icon":1},{"id":"2561289167","title":"Applovin Corporation CTO Vasily Shikin Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2561289167","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561289167?lang=en_us&edition=fundamental","pubTime":"2025-08-23 08:09","pubTimestamp":1755907783,"startTime":"0","endTime":"0","summary":"Vasily Shikin, the Chief Technology Officer of Applovin Corporation, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Applovin Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 22, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250823:nNDLbFfggn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APP","BK4613","BK4023","IE00B894F039.SGD","BK4539","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","IE00B19Z9P08.USD","BK4608","BK4585","BK4588"],"gpt_icon":1},{"id":"2561428991","title":"Arash Adam Foroughi, CEO and Chairperson, Reports Disposal of Common Shares in Applovin Corporation","url":"https://stock-news.laohu8.com/highlight/detail?id=2561428991","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561428991?lang=en_us&edition=fundamental","pubTime":"2025-08-23 08:02","pubTimestamp":1755907370,"startTime":"0","endTime":"0","summary":"Arash Adam Foroughi, CEO and Chairperson of Applovin Corporation, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Applovin Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250823:nNDL2xTkT4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","IE00BZ9MQY76.HKD","BK4539","BK4613","BK4608","IE00B19Z9Z06.USD","BK4588","BK4585","APP","IE00B894F039.SGD","IE00B19Z9P08.USD"],"gpt_icon":1},{"id":"2561289663","title":"BriaCell Therapeutics trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2561289663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561289663?lang=en_us&edition=fundamental","pubTime":"2025-08-23 07:55","pubTimestamp":1755906909,"startTime":"0","endTime":"0","summary":"19:50 EDT BriaCell (BCTX) Therapeutics trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-therapeutics-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-therapeutics-trading-halted-news-pending-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2561286389","title":"thredUP (TDUP) Gets a Buy from William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2561286389","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561286389?lang=en_us&edition=fundamental","pubTime":"2025-08-23 05:55","pubTimestamp":1755899726,"startTime":"0","endTime":"0","summary":"In a report released today, Dylan Carden from William Blair maintained a Buy rating on thredUP. The company’s shares closed today at $11.68. Accord...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/thredup-tdup-gets-a-buy-from-william-blair-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/thredup-tdup-gets-a-buy-from-william-blair-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TDUP","BK4122","BK4539","BK4094"],"gpt_icon":0},{"id":"2561228680","title":"Decoy Therapeutics Reports Financial Downturn Amid Funding Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2561228680","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561228680?lang=en_us&edition=fundamental","pubTime":"2025-08-23 05:53","pubTimestamp":1755899611,"startTime":"0","endTime":"0","summary":"An announcement from Salarius Pharmaceuticals ( ($SLRX) ) is now available. Decoy Therapeutics, Inc. reported a significant financial downturn for ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/decoy-therapeutics-reports-financial-downturn-amid-funding-challenges?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/decoy-therapeutics-reports-financial-downturn-amid-funding-challenges?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2561285872","title":"Why Recursion Pharmaceuticals Stock Caught a Cold This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2561285872","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561285872?lang=en_us&edition=fundamental","pubTime":"2025-08-23 05:53","pubTimestamp":1755899580,"startTime":"0","endTime":"0","summary":"The few news items from and about the company weren't all that positive.","market":"nz","thumbnail":"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F830584%2Fperson-in-a-lab-gazing-into-a-microscope.jpg&op=resize&w=165&h=104","type":0,"news_type":0,"thumbnails":["https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F830584%2Fperson-in-a-lab-gazing-into-a-microscope.jpg&op=resize&w=165&h=104"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/08/22/why-recursion-pharmaceuticals-stock-caught-a-cold/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1720051017.SGD","LU1668664300.SGD","BK4504","IE00BZ1G4Q59.USD","LU1732800096.USD","LU0098860793.USD","LU0158827781.USD","LU0106261372.USD","LU2111349929.HKD","BK4534","LU1244550577.SGD","BK4539","LU0106831901.USD","LU0234570918.USD","LU1162221912.USD","LU1732799900.SGD","LU1989772923.USD","LU2028103732.USD","LU1989772840.SGD","LU2089284900.SGD","LU0795875169.SGD","LU2357305700.SGD","LU1363072403.SGD","LU1548497426.USD","RXRX","LU0267386448.USD","BK4516","IE00BKVL7J92.USD","BK4581","LU1720051108.HKD","BK4139","LU0971096721.USD","LU2023251221.USD","LU2089283258.USD","BK4548","BK4609","LU0314104364.USD","LU0006306889.USD","LU0882574139.USD","LU0795875086.SGD","BK4611","BK4585","LU0158827948.USD","LU0320765646.SGD","LU2271345857.HKD","LU1244550494.USD","BK4588","LU2347655156.SGD","LU1074936037.SGD","BK4127"],"gpt_icon":1},{"id":"2561074283","title":"Chief Medical Officer Hyong Kim Reports Disposal of Common Shares of Alignment Healthcare Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2561074283","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561074283?lang=en_us&edition=fundamental","pubTime":"2025-08-23 05:45","pubTimestamp":1755899102,"startTime":"0","endTime":"0","summary":"Hyong Kim, the Chief Medical Officer of Alignment Healthcare Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alignment Healthcare Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nNDL2yNrJk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ALHC","BK4154"],"gpt_icon":0},{"id":"2561283994","title":"Sarah Personette Joins Lifestance Health Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2561283994","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561283994?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:57","pubTimestamp":1755896247,"startTime":"0","endTime":"0","summary":"Lifestance Health Group ( ($LFST) ) has issued an announcement. On August 19, 2025, William Miller resigned from the board of directors of LifeStan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sarah-personette-joins-lifestance-health-board?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sarah-personette-joins-lifestance-health-board?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4535","LFST","BK4196"],"gpt_icon":0},{"id":"2561283639","title":"UTime Limited Completes $25 Million Share Offering and Announces Board Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2561283639","media":"TIPRANKS","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561283639?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:55","pubTimestamp":1755896118,"startTime":"0","endTime":"0","summary":"The latest announcement is out from UTime ( ($WTO) ). On August 12, 2025, UTime Limited entered into a securities purchase agreement to sell 80 mil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/utime-limited-completes-25-million-share-offering-and-announces-board-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/utime-limited-completes-25-million-share-offering-and-announces-board-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WTO","BK4145","BK4539"],"gpt_icon":0},{"id":"2561885782","title":"Serina Therapeutics Amends Bylaws for Governance Transparency","url":"https://stock-news.laohu8.com/highlight/detail?id=2561885782","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561885782?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:31","pubTimestamp":1755894701,"startTime":"0","endTime":"0","summary":"Serina Therapeutics ( ($SER) ) has issued an announcement. On August 18, 2025, Serina Therapeutics‘ Board of Directors amended the company’s bylaws...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/serina-therapeutics-amends-bylaws-for-governance-transparency?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/serina-therapeutics-amends-bylaws-for-governance-transparency?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2561400702","title":"Rain Enhancement Technologies Holdco Inc. Appeals Nasdaq Delisting Notice; Awaits Hearing to Regain Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2561400702","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561400702?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:30","pubTimestamp":1755894614,"startTime":"0","endTime":"0","summary":"Rain Enhancement Technologies Holdco, Inc.  has received a notice from the Nasdaq Stock Market regarding its non-compliance with specific market value requirements. The company has until August 26, 2025, to appeal this decision. It has already requested a hearing, which is expected to delay any suspension or delisting actions. During the hearing, Rain Enhancement Technologies plans to present its strategy to regain compliance with Nasdaq's listing criteria. The company's status on the Nasdaq Global Market remains uncertain, pending the outcome of the hearing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rain Enhancement Technologies Holdco Inc. published the original content used to generate this news brief via GlobeNewswire  on Augu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nNDL60m31X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4161","BK4539","BK4112","IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","BK4585","RAIN","BK4007","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","NDAQ","LU2210149790.SGD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2561400736","title":"Rain Enhancement Technologies Holdco, Inc. Receives and Appeals Nasdaq Delisting Notice","url":"https://stock-news.laohu8.com/highlight/detail?id=2561400736","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561400736?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:30","pubTimestamp":1755894600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nTUA6KGRVP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RAIN","BK4539","BK4161","BK4007"],"gpt_icon":0},{"id":"2561728865","title":"Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2561728865","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561728865?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:28","pubTimestamp":1755894486,"startTime":"0","endTime":"0","summary":"Chemomab Therapeutics ( ($CMMB) ) has shared an update. Chemomab Therapeutics Ltd. announced a change in the ratio of its American Depositary Share...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chemomab-therapeutics-announces-ads-ratio-change-effective-august-26-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chemomab-therapeutics-announces-ads-ratio-change-effective-august-26-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2561400612","title":"TScan Therapeutics Inc. Files Initial Beneficial Ownership Statement for Principal Accounting Officer Dworak Leiden","url":"https://stock-news.laohu8.com/highlight/detail?id=2561400612","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561400612?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:10","pubTimestamp":1755893432,"startTime":"0","endTime":"0","summary":"TScan Therapeutics Inc. has filed an initial statement of beneficial ownership for Dworak Leiden, who serves as the Principal Accounting Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. TScan Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nNDLb15KlY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","TCRX"],"gpt_icon":0},{"id":"2561400532","title":"Lyell Immunopharma's Chief Scientific Officer Gary K. Lee Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2561400532","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561400532?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:03","pubTimestamp":1755892981,"startTime":"0","endTime":"0","summary":"Gary K. Lee, the Chief Scientific Officer of Lyell Immunopharma Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 22, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nNDL9yyrzR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","BK4539","LYEL"],"gpt_icon":0}],"pageSize":20,"totalPage":57,"pageCount":2,"totalSize":1136,"code":"91000000","status":"200"}]}}